423 related articles for article (PubMed ID: 27543219)
1. Hidradenitis suppurativa (HS) and Down syndrome (DS): Increased prevalence and a younger age of hidradenitis symptom onset.
Denny G; Anadkat MJ
J Am Acad Dermatol; 2016 Sep; 75(3):632-634. PubMed ID: 27543219
[No Abstract] [Full Text] [Related]
2. Hidradenitis Suppurativa Associated with Down Syndrome Is Characterized by Early Age at Diagnosis.
Giovanardi G; Chiricozzi A; Bianchi L; De Simone C; Dini V; Franceschini C; Garcovich S; Oranges T; Di Raimondo C; Caposiena Caro DR; Romanelli M; Peris K
Dermatology; 2018; 234(1-2):66-70. PubMed ID: 29689550
[TBL] [Abstract][Full Text] [Related]
3. The prevalence of metabolic syndrome in patients with hidradenitis suppurativa.
Gold DA; Reeder VJ; Mahan MG; Hamzavi IH
J Am Acad Dermatol; 2014 Apr; 70(4):699-703. PubMed ID: 24433875
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of type 2 diabetes mellitus among patients with hidradenitis suppurativa in the United States.
Garg A; Birabaharan M; Strunk A
J Am Acad Dermatol; 2018 Jul; 79(1):71-76. PubMed ID: 29339240
[TBL] [Abstract][Full Text] [Related]
5. Hidradenitis suppurativa: Epidemiology and scope of the problem.
Jemec GB; Kimball AB
J Am Acad Dermatol; 2015 Nov; 73(5 Suppl 1):S4-7. PubMed ID: 26470614
[TBL] [Abstract][Full Text] [Related]
6. Hidradenitis suppurativa in the pediatric population.
Liy-Wong C; Pope E; Lara-Corrales I
J Am Acad Dermatol; 2015 Nov; 73(5 Suppl 1):S36-41. PubMed ID: 26470613
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of hidradenitis suppurativa among patients with Down syndrome: a population-based cross-sectional analysis.
Garg A; Strunk A; Midura M; Papagermanos V; Pomerantz H
Br J Dermatol; 2018 Mar; 178(3):697-703. PubMed ID: 28662304
[TBL] [Abstract][Full Text] [Related]
8. High prevalence of clinical spondyloarthritis features in patients with hidradenitis suppurativa.
Rondags A; van Straalen KR; Arends S; van der Zee HH; Prens EP; Spoorenberg A; Horváth B
J Am Acad Dermatol; 2019 Feb; 80(2):551-554.e1. PubMed ID: 30554892
[No Abstract] [Full Text] [Related]
9. Prevalence and Description of Hidradenitis Suppurativa in Down Syndrome: A Cross-sectional Study of 783 Subjects.
Poizeau F; Sbidian E; Mircher C; Rebillat AS; Chosidow O; Wolkenstein P; Ravel A; Hotz C
Acta Derm Venereol; 2019 Mar; 99(3):351-352. PubMed ID: 30460373
[No Abstract] [Full Text] [Related]
10. Hidradenitis suppurativa (HS) is associated with low socioeconomic status (SES): A cross-sectional reference study.
Deckers IE; Janse IC; van der Zee HH; Nijsten T; Boer J; Horváth B; Prens EP
J Am Acad Dermatol; 2016 Oct; 75(4):755-759.e1. PubMed ID: 27453539
[TBL] [Abstract][Full Text] [Related]
11. Color Doppler ultrasound assessment of morphology and types of fistulous tracts in hidradenitis suppurativa (HS).
Wortsman X; Castro A; Figueroa A
J Am Acad Dermatol; 2016 Oct; 75(4):760-767. PubMed ID: 27498279
[TBL] [Abstract][Full Text] [Related]
12. Systemic associations of hidradenitis suppurativa.
Kohorst JJ; Kimball AB; Davis MD
J Am Acad Dermatol; 2015 Nov; 73(5 Suppl 1):S27-35. PubMed ID: 26470611
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of hidradenitis suppurativa in Brazil: a population survey.
Ianhez M; Schmitt JV; Miot HA
Int J Dermatol; 2018 May; 57(5):618-620. PubMed ID: 29517130
[No Abstract] [Full Text] [Related]
14. Hidradenitis suppurativa and Down syndrome in a single-centre sample: A cross-sectional study.
Hernández-Rodríguez JC; Osorio-Gómez GF; Ortiz-Álvarez J; Lebrón-Martín JA; Conejo-Mir J; Pereyra-Rodríguez JJ
Australas J Dermatol; 2022 Aug; 63(3):e231-e237. PubMed ID: 35567765
[TBL] [Abstract][Full Text] [Related]
15. A retrospective study of the characteristics of patients with early-onset compared to adult-onset hidradenitis suppurativa.
Dessinioti C; Tzanetakou V; Zisimou C; Kontochristopoulos G; Antoniou C
Int J Dermatol; 2018 Jun; 57(6):687-691. PubMed ID: 29604044
[TBL] [Abstract][Full Text] [Related]
16. Association Between Hidradenitis Suppurativa and Lymphoma.
Tannenbaum R; Strunk A; Garg A
JAMA Dermatol; 2019 May; 155(5):624-625. PubMed ID: 30698627
[TBL] [Abstract][Full Text] [Related]
17. Hidradenitis suppurativa and associated factors: still unsolved problems.
Matusiak L; Bieniek A; Szepietowski JC
J Am Acad Dermatol; 2009 Aug; 61(2):362-5. PubMed ID: 19615551
[No Abstract] [Full Text] [Related]
18. Demographic and clinical features of hidradenitis suppurativa in Korea.
Yang JH; Moon J; Kye YC; Kim KJ; Kim MN; Ro YS; Park MY; Ahn HH; Lee MW; Lee WJ; Lee JH; Lee JB; Jang MS; Choi YS; Choi YW; Suh DH;
J Dermatol; 2018 Dec; 45(12):1389-1395. PubMed ID: 30294846
[TBL] [Abstract][Full Text] [Related]
19. Hidradenitis suppurativa in children: The Henry Ford experience.
Braunberger TL; Nicholson CL; Gold L; Nahhas AF; Jacobsen G; Parks-Miller A; Hamzavi IH
Pediatr Dermatol; 2018 May; 35(3):370-373. PubMed ID: 29575194
[TBL] [Abstract][Full Text] [Related]
20. Adolescent-Onset Hidradenitis Suppurativa: Prevalence, Risk Factors and Disease Features.
Molina-Leyva A; Cuenca-Barrales C
Dermatology; 2019; 235(1):45-50. PubMed ID: 30368494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
